BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18660670)

  • 1. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
    Liu S; Gupta A; Quarles LD
    Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
    Galitzer H; Ben-Dov I; Lavi-Moshayoff V; Naveh-Many T; Silver J
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal phosphate handling in human--what can we learn from hereditary hypophosphataemias?
    Amatschek S; Haller M; Oberbauer R
    Eur J Clin Invest; 2010 Jun; 40(6):552-60. PubMed ID: 20412291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets.
    Beck-Nielsen SS; Brixen K; Gram J; Brusgaard K
    J Hum Genet; 2012 Jul; 57(7):453-8. PubMed ID: 22695891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
    Ichikawa S; Austin AM; Gray AK; Econs MJ
    J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone as a source of FGF23: regulation by phosphate?
    Mirams M; Robinson BG; Mason RS; Nelson AE
    Bone; 2004 Nov; 35(5):1192-9. PubMed ID: 15542045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
    FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.
    Liu S; Guo R; Simpson LG; Xiao ZS; Burnham CE; Quarles LD
    J Biol Chem; 2003 Sep; 278(39):37419-26. PubMed ID: 12874285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hypophosphatemias: new genes in the bone-kidney axis.
    Negri AL
    Nephrology (Carlton); 2007 Aug; 12(4):317-20. PubMed ID: 17635744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phex mutation causes overexpression of FGF23 in teeth.
    Onishi T; Umemura S; Shintani S; Ooshima T
    Arch Oral Biol; 2008 Feb; 53(2):99-104. PubMed ID: 17942069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.
    Lorenz-Depiereux B; Bastepe M; Benet-Pagès A; Amyere M; Wagenstaller J; Müller-Barth U; Badenhoop K; Kaiser SM; Rittmaster RS; Shlossberg AH; Olivares JL; Loris C; Ramos FJ; Glorieux F; Vikkula M; Jüppner H; Strom TM
    Nat Genet; 2006 Nov; 38(11):1248-50. PubMed ID: 17033625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.